Insider Transactions Reported by 20 Insiders of Amneal Pharmaceuticals, Inc.

Symbol
AMRX on Nasdaq
Location
Bridgewater, NJ

Insiders trading volume in the past year

Amneal Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Tushar Patel 10%+ Owner $405,628,045 -$41,750,000 -9.3% 14 Mar 2025
Chintu Patel Co-CEO, Director $236,783,582 03 Mar 2025
Chirag K. Patel President & Co-CEO, Director $205,932,998 03 Mar 2025
Dipan Patel Member of 13D Group $111,029,165 07 Nov 2023
TPG GP A, LLC Former 10% Owner $50,877,123 12 Dec 2022
Gautam Patel Director $12,905,334 -$3,811,573 -23% 16 Jun 2025
PAUL M. MEISTER Director $6,570,364 05 May 2025
Tasos Konidaris Executive Vice President & CFO $4,336,547 -$5,554,070 -56% 13 Aug 2025
Nikita Shah Executive Vice President $4,311,409 -$4,228,465 -50% 12 Nov 2025
ANDREW S. BOYER Executive Vice President $4,158,186 -$4,033,155 -49% 20 Aug 2025
Ted C. Nark Director $3,410,859 -$586,000 -15% 17 Nov 2025
Joseph Todisco Executive Vice President $2,935,743 07 May 2022
Jason B. Daly EVP, Chief Legal Officer $2,763,048 -$991,260 -26% 12 Aug 2025
Jeffrey P. George Director $2,596,082 05 May 2025
Gustavo Pesquin Title: Executive Vice President, Chief Commercial Officer - Specialty $2,537,775 06 Sep 2022
J. KEVIN BUCHI Director $2,533,525 05 May 2025
Shlomo Yanai Director $2,396,554 05 May 2025
John Kiely Director $2,080,746 -$674,860 -24% 27 Aug 2025
Emily Peterson Alva Director $1,768,423 -$712,000 -29% 05 May 2025
Deborah M. Autor Director $784,870 05 May 2025

Recent Insider Transactions by Companies or Individuals for Amneal Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.